Clinical Trials Browser

Breast Neoplasms

NCT00382070 2024-03-22

Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer

Phase 3 Unknown

3,966 enrolled 12 charts

Breast

Breast Neoplasms

NCT03423199 2024-03-22

PATHWAY

Phase 3 Unknown

180 enrolled

Breast

Breast Neoplasms, Neoplasm Metastasis

NCT04400695 2024-01-24

A Study of RC48-ADC for the Treatment of Locally Advanced or Metastatic Breast Cancer With Low Expression of HER2

Phase 3 Unknown

366 enrolled

Breast

Breast Neoplasms

NCT06152471 2023-11-30

ASF-BC

Phase 3 Unknown

100 enrolled

Breast

Breast Neoplasms, Diarrhea, Drug-Related Side Effects and Adverse Reactions

NCT03926091 2023-11-14

CLOVER

Phase 3 Unknown

2,172 enrolled

Breast

Breast Neoplasms

NCT05673629 2023-11-08

Utidelone in Combination With AC Versus Docetaxel in Combination With AC for Neoadjuvant Chemotherapy in Patients With HER2-negative Breast Cancer

Phase 3 Unknown

552 enrolled

Breast

Breast Neoplasms

NCT05144867 2023-10-17

SRSvsWBRT

Phase 3 Unknown

98 enrolled

BreastCNS

Brain Neoplasms, Breast Neoplasms

NCT05755048 2023-09-01

FS-1502 Versus T-DM1 for HER2-Positive Unresectable Locally Advanced or Metastatic Breast Cancer

Phase 3 Unknown

314 enrolled

Breast

Breast Neoplasms

NCT05433480 2023-07-27

A Study of BPI-16350 in Combination With Fulvestrant in Patients With HR+ and HER2- Locally Advanced, Recurrent or Metastatic Breast Cancer

Phase 3 Unknown

274 enrolled

Breast

Breast Neoplasms

NCT01579734 2023-06-28

HOT

Phase 3 Unknown

1,884 enrolled

Breast

Breast Neoplasms

NCT03613181 2023-04-24

ANGLeD

Phase 3 Unknown

150 enrolled

BreastCNS

Brain Neoplasms, Breast Neoplasms, Meningeal Neoplasms, Meningeal Carcinomatosis

NCT05790096 2023-03-29

Effectiveness and Safety Study of Filgrastine® in Patientes With Breast Cancer Treated With Myelotoxic Chemotherapy

Phase 3 Unknown

60 enrolled

Breast

Breast Neoplasms

NCT00412022 2023-03-24

HOBOE

Phase 3 Unknown

1,294 enrolled

Breast

Breast Neoplasms

NCT05728632 2023-02-23

CONTROL

Phase 3 Unknown

80 enrolled

BreastLymphoid

Breast Neoplasms, Lymphoma, Large B-Cell, Diffuse, Ventricular Dysfunction, Left, Cardiotoxicity

NCT05637671 2023-02-08

Efficacy and Safety of Oxybutynin Versus Paroxetine in Aromatase Inhibitor-induced Vasomotor Symptoms

Phase 3 Unknown

146 enrolled

Breast

Breast Neoplasms, Hot Flashes

NCT02914158 2023-01-17

ASPAIT

Phase 3 Unknown

680 enrolled

Breast

Breast Neoplasms

NCT05670054 2023-01-04

Cyclin Dependant Kinase 4/6 (CDK4/6) Inhibitors as a Second Line Treatment in Metastatic Breast Cancer Patients

Phase 3 Unknown

116 enrolled

Breast

Breast Neoplasms

NCT03863223 2022-11-23

A Study of Pyrotinib in Combination With Trastuzumab and Docetaxel in Patients With HER2 Metastatic Breast Cancer

Phase 3 Unknown

590 enrolled

Breast

Breast Neoplasms

NCT00887380 2022-11-18

STARS

Phase 3 Unknown

2,023 enrolled

Breast

Breast Neoplasms

NCT02786875 2022-05-23

DEDiCa

Phase 3 Unknown

506 enrolled

Breast

Breast Neoplasms, Motor Activity

NCT02062489 2022-04-27

Evaluation of Tamoxifen's Efficacy for ER/PR Negative,ER-beta Positive Operable Breast Cancer Patients

Phase 3 Unknown

688 enrolled

Breast

Breast Neoplasms

NCT05346861 2022-04-26

Pyrotinib Rechallenge in Her2-positive Metastatic Breast Cancer Pretreated With Pyrotinib and Trastuzumab

Phase 3 Unknown

240 enrolled

Breast

Breast Neoplasms

NCT01547741 2022-04-14

Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer

Phase 3 Unknown

1,871 enrolled

Breast

Breast Neoplasms

NCT04918589 2022-04-06

Tranexamic Acid for Alloplastic Breast Reconstruction

Phase 3 Unknown

106 enrolled

Breast

Breast Neoplasms

NCT02236806 2022-02-01

SAFE

Phase 3 Unknown

262 enrolled

Breast

Breast Neoplasms, Cardiotoxicity

NCT00212121 2022-01-21

Radiation Dose Intensity Study in Breast Cancer in Young Women

Phase 3 Unknown

2,400 enrolled

Breast

Breast Neoplasms

NCT04646564 2022-01-11

Radiotherapy for Extracranial Oligometastatic Breast Cancer

Phase 3 Unknown

170 enrolled

Breast

Breast Neoplasms

NCT05164952 2021-12-21

Delayed Versus Immediate Use Of Zoledronic Acid For Postmenopausal Patients With Early Breast Cancer Who Are Using Adjuvant Letrozole

Phase 3 Unknown

50 enrolled

Breast

Breast Neoplasms

NCT04612439 2021-09-14

Accuracy of VABB Elite 10G Versus BARD 14G CNB

Phase 3 Unknown

1,470 enrolled

Breast

Breast Neoplasms

NCT04047758 2021-07-20

Palbociclib Combined With an Aromatase Inhibitor in Breast Cancer

Phase 3 Unknown

420 enrolled

Breast

Breast Neoplasms

NCT03980054 2021-05-24

A Study of Evaluating The Effects Of Pyrotinib After Adjuvant Trastuzumab In Women With Early Stage Breast Cancer

Phase 3 Unknown

1,192 enrolled

Breast

Breast Neoplasms

NCT04240548 2021-04-01

Radiation Therapy for ypN0 Breast Cancer

Phase 3 Unknown

160 enrolled

Breast

Breast Neoplasms

NCT04803266 2021-03-17

Elective Internal Mammary Node Irradiation in Women With Node-positive Breast Cancer

Phase 3 Unknown

747 enrolled

Breast

Breast Neoplasms

NCT04665986 2020-12-14

Neoadjuvant Study of Navelbine in Patients With HER2 Positive Breast Cancer

Phase 3 Unknown

50 enrolled

Breast

Breast Neoplasms

NCT01917279 2020-07-23

CAMELLIA

Phase 3 Unknown

280 enrolled

Breast

Breast Diseases, Breast Neoplasms, Neoplasm Metastasis, Neoplasms by Site, Skin Diseases

NCT04337658 2020-04-08

FAVOR

Phase 3 Unknown

493 enrolled

Breast

Breast Neoplasms

NCT04307147 2020-03-13

NX in Luminal B Breast Cancer Patients After Neoadjuvant Chemotherapy

Phase 3 Unknown

316 enrolled

Breast

Breast Neoplasms

NCT01758146 2020-03-04

Impact of Obesity on the Efficacy of Endocrine Therapy With Aromatase Inhibitors

Phase 3 Unknown

412 enrolled

BreastOther

Breast Neoplasms, Obesity

NCT00541086 2020-02-07

Study of Anastrozole, Letrozole, or Exemestane With or Without Tamoxifen in Treating Postmenopausal Women With Hormone-Responsive Breast Cancer That Has Been Completely Removed By Surgery

Phase 3 Unknown

3,697 enrolled

Breast

Breast Neoplasms

NCT03971019 2019-08-14

SBSBC

Phase 3 Unknown

314 enrolled

Breast

Breast Neoplasms

NCT03544762 2019-05-30

breast

Phase 3 Unknown

60 enrolled

Breast

Breast Neoplasms

NCT03949634 2019-05-14

Cardiac Safety and Efficacy for Early-stage Breast Cancer Patients Treated With Pegylated Liposomal Doxorubicin（PLD)

Phase 3 Unknown

272 enrolled

Breast

Breast Neoplasms

NCT00532727 2019-02-20

TNT

Phase 3 Unknown

400 enrolled

Breast

Breast Neoplasms

NCT02751606 2018-12-06

Nano MRI on 7 Tesla in Rectal and Breast Cancer

Phase 3 Unknown

30 enrolled

BreastGastrointestinal

Breast Neoplasms, Rectal Neoplasms

NCT03731026 2018-11-06

The LightPath® and 68Ga-RM2 in Breast Cancer Study

Phase 3 Unknown

80 enrolled

Breast

Breast Neoplasms

NCT03137368 2018-10-31

STEP

Phase 3 Unknown

300 enrolled

Breast

Breast Neoplasms

NCT01104571 2018-09-17

EPHOS-B

Phase 3 Unknown

257 enrolled

Breast

Breast Neoplasms

NCT00301925 2018-08-08

TACT2

Phase 3 Unknown

4,400 enrolled

Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT02898376 2018-08-08

FIBROTHERME

Phase 3 Unknown

142 enrolled

Breast

Breast Neoplasms, Fibrosis

Clinical Trials

Carboplatin in EARLY Triple Negative Breast Cancer Trial (PEARLY Trial)

Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer

PATHWAY

A Study of RC48-ADC for the Treatment of Locally Advanced or Metastatic Breast Cancer With Low Expression of HER2

ASF-BC

CLOVER

Utidelone in Combination With AC Versus Docetaxel in Combination With AC for Neoadjuvant Chemotherapy in Patients With HER2-negative Breast Cancer

SRSvsWBRT

FS-1502 Versus T-DM1 for HER2-Positive Unresectable Locally Advanced or Metastatic Breast Cancer

A Study of BPI-16350 in Combination With Fulvestrant in Patients With HR+ and HER2- Locally Advanced, Recurrent or Metastatic Breast Cancer

HOT

ANGLeD

Effectiveness and Safety Study of Filgrastine® in Patientes With Breast Cancer Treated With Myelotoxic Chemotherapy

HOBOE

CONTROL

Efficacy and Safety of Oxybutynin Versus Paroxetine in Aromatase Inhibitor-induced Vasomotor Symptoms

ASPAIT

Cyclin Dependant Kinase 4/6 (CDK4/6) Inhibitors as a Second Line Treatment in Metastatic Breast Cancer Patients

A Study of Pyrotinib in Combination With Trastuzumab and Docetaxel in Patients With HER2 Metastatic Breast Cancer

STARS

DEDiCa

Evaluation of Tamoxifen's Efficacy for ER/PR Negative,ER-beta Positive Operable Breast Cancer Patients

Pyrotinib Rechallenge in Her2-positive Metastatic Breast Cancer Pretreated With Pyrotinib and Trastuzumab

Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer

Tranexamic Acid for Alloplastic Breast Reconstruction

SAFE

Radiation Dose Intensity Study in Breast Cancer in Young Women

Radiotherapy for Extracranial Oligometastatic Breast Cancer

Delayed Versus Immediate Use Of Zoledronic Acid For Postmenopausal Patients With Early Breast Cancer Who Are Using Adjuvant Letrozole

Accuracy of VABB Elite 10G Versus BARD 14G CNB

Palbociclib Combined With an Aromatase Inhibitor in Breast Cancer

A Study of Evaluating The Effects Of Pyrotinib After Adjuvant Trastuzumab In Women With Early Stage Breast Cancer

Radiation Therapy for ypN0 Breast Cancer

Elective Internal Mammary Node Irradiation in Women With Node-positive Breast Cancer

Neoadjuvant Study of Navelbine in Patients With HER2 Positive Breast Cancer

CAMELLIA

FAVOR

NX in Luminal B Breast Cancer Patients After Neoadjuvant Chemotherapy

Impact of Obesity on the Efficacy of Endocrine Therapy With Aromatase Inhibitors

Study of Anastrozole, Letrozole, or Exemestane With or Without Tamoxifen in Treating Postmenopausal Women With Hormone-Responsive Breast Cancer That Has Been Completely Removed By Surgery

SBSBC

breast

Cardiac Safety and Efficacy for Early-stage Breast Cancer Patients Treated With Pegylated Liposomal Doxorubicin（PLD)

TNT

Nano MRI on 7 Tesla in Rectal and Breast Cancer

The LightPath® and 68Ga-RM2 in Breast Cancer Study

STEP

EPHOS-B

TACT2

FIBROTHERME